Impact of short-term pausing of oral corticosteroids on blood eosinophil count in patients with severe asthma
Pneumologie · 01.06.2023 · 77 (06) · 357-362
DOI: 10.1055/a-1956-8800 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Pneumologie, erschienen am 01.06.2023. Verfasst von Leonie Biener und 5 weiteren Autor:innen. Beteiligte Einrichtung: Internal Medicine II - Kardiology, Pneumology, Angiology, University Hospital Bonn Center of Internal Medicine, Bonn, Germany. Hauptthemen laut MEDLINE: Anti-Asthmatic Agents, Asthma, Eosinophilia. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 9 Literaturangaben.
Abstract (Originalsprache)
Background
The peripheral blood eosinophil count (BEC) is a well-established and easily accessible biomarker for asthma patients and crucial for the therapeutic decision regarding monoclonal antibody (mAB) therapy. Oral corticosteroid therapy frequently hinders the correct evaluation of BEC in patients with severe asthma, but a discontinuation of such therapy frequently comes along with severe side effects. Therefore, we examined the effect of a short 24-hour pause of OCS treatment on BEC in patients with severe asthma and followed-up whether patients with a then increased eosinophil count benefited from mAB-therapy, as expected.
Methods
In this multicentre study we retrospectively included 24 patients with severe asthma and OCS therapy and determined their BEC count. Ten patients, where BEC count was obtained in the morning before taking medication (a de-facto 24-hour OCS pause), were assigned to group 1. Fourteen patients, where BEC was obtained after OCS tapering were assigned to group 2. Those who then received mAB treatment were followed up for treatment response (OCS dose, annual acute exacerbations, increase in forced expiratory volume in one second [FEV1] and asthma control test [ACT]) after ≥3 months.
Results
We included 24 patients with a median age of 60.5 [IQR: 17.3] years. Regarding all baseline characteristics except FEV1 (l), both groups did not differ significantly. Among all 24 patients, after pausing OCS therapy for 2 [5.5] days the BEC increased significantly from 125.0/μl [125] to 300/μl [232.5] (p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Internal Medicine II - Kardiology, Pneumology, Angiology, University Hospital Bonn Center of Internal Medicine, Bonn, Germany.
- Department of Medicine V, LMU, Munchen, Germany.
- Comprehensive Pneumology Center (CPC-M), LMU and Helmholtz Center Munich, Member of the German Center for Lung Research (DZL), Munich, Germany.
- Department of Respiratory Medicine, Hannover Medical School, Hannover, Germany.
- Pneumologie, IKF, Mainz, Germany.
- Thoraxklinik, Universitätsklinikum Heidelberg, Heidelberg, Germany.
ORCID-Profile: Leonie Biener, Katrin Milger
Zitieren
APA
Biener, L., Milger, K., Suhling, H., Korn, S., Pizarro, C., & Skowasch, D. (2023). Impact of short-term pausing of oral corticosteroids on blood eosinophil count in patients with severe asthma. Pneumologie, 77(06), 357-362. https://doi.org/10.1055/a-1956-8800
Vancouver
Biener L, Milger K, Suhling H, Korn S, Pizarro C, Skowasch D. Impact of short-term pausing of oral corticosteroids on blood eosinophil count in patients with severe asthma. Pneumologie. 2023;77(06):357-362. doi:10.1055/a-1956-8800
BibTeX
@article{Biener2023,
author = {Biener, Leonie and Milger, Katrin and Suhling, Hendrik and Korn, Stephanie and Pizarro, Carmen and Skowasch, Dirk},
title = {Impact of short-term pausing of oral corticosteroids on blood eosinophil count in patients with severe asthma},
journal = {Pneumologie},
year = {2023},
volume = {77},
number = {06},
pages = {357--362},
doi = {10.1055/a-1956-8800}
}
EUVIMED